phosphate buffered saline (PBS) [46,47] |
pH constant 7.4, the proximity of its ions to the ions of the body (%) |
calcium alginate hydrogel [58] |
stability at 37 °C, the feasibility to adapt gel strength and elasticity, mild gelling conditions, feasibility of incorporation the diverse substances such as proteins or living cells |
9:1 (v/v) of normal saline and isopropanol [53] |
suitable medium for in vitro release of sirolimus |
3 wt.% alginate; 2 wt.% agar; 2 wt.% agarose; 10 wt.% PAA; 15 wt.% PVA [59] |
agarose: long-term dissolution |
deionized water, PBS, phosphate-buffer (PB) [34] |
deionized water increased the release compared to PBS and PB |
calcium alginate; polyacrylamide (PAAm); poly(vinylethy limidazolium bromide [61] |
disadvantages of calcium alginate: dissolution of the network by monovalent cations (like Na+) and its susceptibility to microbial contamination |
surfactant 0.1% P123 (kind of PEO–PPO–PEO block copolymers) in phosphate buffer pH 4.0 [54] |
suitable for in vitro release of sirolimus |
alginate-based gel containing microparticles LiChroprep® RP-18 or mediumchain triglycerides [64] |
additives improved the transfer of hydrophobic drugs into the hydrogel but had no significant effect on the hydrophilic drugs |
glycerol-water (40/60 vol%, 0.01% surfactant) [41,43] |
|
deionized water, PBS, and PB as the base for preparing hydrogel [34] |
more drug transfer to deionized waterbased hydrogels than PBS and PB-based hydrogels |
2% ultra-pure sodium dodecyl sulfate (SDS), in high purity water with 10% gradient-grade acetonitrile (ACN), and buffered to pH 4.5 with phosphate+ 55:45:0.02 water/tetrahydrofuran (THF)/formic acid (v/v) [56] |
good correlate between in vitro release profile with in vivo from porcine |
|
|
87% of glycerol and 13% of water [45] |
approaching to the viscosity of blood |
|
|